NZ264661A - 1-naphthyl-3-pyrazolecarboxamide derivatives and medicaments; intermediate 4-hydrazino-1-naphthylene(nitrile) and -acetic acid - Google Patents
1-naphthyl-3-pyrazolecarboxamide derivatives and medicaments; intermediate 4-hydrazino-1-naphthylene(nitrile) and -acetic acidInfo
- Publication number
- NZ264661A NZ264661A NZ264661A NZ26466194A NZ264661A NZ 264661 A NZ264661 A NZ 264661A NZ 264661 A NZ264661 A NZ 264661A NZ 26466194 A NZ26466194 A NZ 26466194A NZ 264661 A NZ264661 A NZ 264661A
- Authority
- NZ
- New Zealand
- Prior art keywords
- ppm
- mixture
- acid
- compound
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/10—Hydrazines
- C07C243/22—Hydrazines having nitrogen atoms of hydrazine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/63—Carboxylic acid nitriles containing cyano groups and nitrogen atoms further bound to other hetero atoms, other than oxygen atoms of nitro or nitroso groups, bound to the same carbon skeleton
- C07C255/65—Carboxylic acid nitriles containing cyano groups and nitrogen atoms further bound to other hetero atoms, other than oxygen atoms of nitro or nitroso groups, bound to the same carbon skeleton with the nitrogen atoms further bound to nitrogen atoms
- C07C255/66—Carboxylic acid nitriles containing cyano groups and nitrogen atoms further bound to other hetero atoms, other than oxygen atoms of nitro or nitroso groups, bound to the same carbon skeleton with the nitrogen atoms further bound to nitrogen atoms having cyano groups and nitrogen atoms being part of hydrazine or hydrazone groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9312136A FR2711140B1 (fr) | 1993-10-12 | 1993-10-12 | 1-Naphtylpyrazole-3-carboxamides substitués actifs sur la neurotensine, leur préparation, les compositions pharmaceutiques en contenant. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ264661A true NZ264661A (en) | 1996-08-27 |
Family
ID=9451754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ264661A NZ264661A (en) | 1993-10-12 | 1994-10-12 | 1-naphthyl-3-pyrazolecarboxamide derivatives and medicaments; intermediate 4-hydrazino-1-naphthylene(nitrile) and -acetic acid |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US5502059A (OSRAM) |
| EP (1) | EP0647629B1 (OSRAM) |
| JP (1) | JPH07278114A (OSRAM) |
| KR (1) | KR950011413A (OSRAM) |
| CN (1) | CN1108651A (OSRAM) |
| AT (1) | ATE181911T1 (OSRAM) |
| AU (1) | AU685154B2 (OSRAM) |
| CA (1) | CA2117821A1 (OSRAM) |
| DE (1) | DE69419377D1 (OSRAM) |
| FI (1) | FI944770L (OSRAM) |
| FR (1) | FR2711140B1 (OSRAM) |
| HU (1) | HUT70048A (OSRAM) |
| IL (1) | IL111239A0 (OSRAM) |
| NO (1) | NO304595B1 (OSRAM) |
| NZ (1) | NZ264661A (OSRAM) |
| RU (1) | RU2140912C1 (OSRAM) |
| TW (1) | TW300890B (OSRAM) |
| ZA (1) | ZA947957B (OSRAM) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6716991B1 (en) | 1993-11-30 | 2004-04-06 | G. D. Searle & Co. | Process for preparing a substituted pyrazolyl benzenesulfonamide for the treatment of inflammation |
| US6492411B1 (en) | 1993-11-30 | 2002-12-10 | G. D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation |
| FR2732967B1 (fr) * | 1995-04-11 | 1997-07-04 | Sanofi Sa | 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant |
| FR2741621B1 (fr) * | 1995-11-23 | 1998-02-13 | Sanofi Sa | Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant |
| FR2742148B1 (fr) * | 1995-12-08 | 1999-10-22 | Sanofi Sa | Nouveaux derives du pyrazole-3-carboxamide, procede pour leur preparation et compositions pharmaceutiques les contenant |
| US6521561B1 (en) | 1998-05-01 | 2003-02-18 | President And Fellows Of Harvard College | Main-group metal based asymmetric catalysts and applications thereof |
| IL142707A0 (en) | 2000-04-27 | 2002-03-10 | Pfizer Prod Inc | Methods of treating obesity using a neurotensin receptor ligand |
| KR100425881B1 (ko) * | 2001-03-14 | 2004-04-03 | 고광호 | 신규한 몰피난 유도체 |
| WO2002092695A1 (en) * | 2001-05-11 | 2002-11-21 | Mitsui Chemicals, Inc. | Dopant agent and electroconductive polymer material comprising the same |
| US6603000B2 (en) | 2001-07-11 | 2003-08-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | Synthesis for heteroarylamine compounds |
| DE60108183T2 (de) * | 2001-07-11 | 2005-12-22 | Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield | Neue Synthese für Heteroarylamine Verbindungen |
| AR038967A1 (es) * | 2002-03-18 | 2005-02-02 | Solvay Pharm Bv | Derivados de 2,3 - diaril - pirazolidinas como inhibidores de enzimas que degradan la neurotensina |
| GB0225548D0 (en) | 2002-11-01 | 2002-12-11 | Glaxo Group Ltd | Compounds |
| GB0323585D0 (en) * | 2003-10-08 | 2003-11-12 | Glaxo Group Ltd | Compounds |
| CA2594488C (en) * | 2005-01-10 | 2015-04-28 | University Of Connecticut | Novel heteropyrrole analogs acting on cannabinoid receptors |
| US7714014B2 (en) * | 2005-12-09 | 2010-05-11 | The Regents Of The University Of California | Targeting GLI proteins in human cancer by small molecules |
| DK1988777T3 (da) | 2006-02-09 | 2012-01-16 | Athersys Inc | Pyrazoler til behandling af fedme og andre cns-lidelser |
| EP2740726A1 (en) * | 2012-12-07 | 2014-06-11 | 3B Pharmaceuticals GmbH | Neurotensin receptor ligands |
| PE20170664A1 (es) | 2014-06-06 | 2017-06-10 | Res Triangle Inst | Agonistas del receptor de apelina(apj) y usos de los mismos |
| PE20190258A1 (es) | 2015-12-09 | 2019-02-25 | Res Triangle Inst | Antagonistas del receptor de la apelina (apj) mejorados y usos de los mismos |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3719924A1 (de) * | 1986-12-22 | 1988-06-30 | Bayer Ag | 8-substituierte 2-aminotetraline |
| PH27357A (en) * | 1989-09-22 | 1993-06-21 | Fujisawa Pharmaceutical Co | Pyrazole derivatives and pharmaceutical compositions comprising the same |
| FR2665898B1 (fr) * | 1990-08-20 | 1994-03-11 | Sanofi | Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| US5288877A (en) * | 1991-07-03 | 1994-02-22 | Ppg Industries, Inc. | Continuous process for preparing indolenine compounds |
| IL104311A (en) * | 1992-02-05 | 1997-07-13 | Fujisawa Pharmaceutical Co | Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
-
1993
- 1993-10-12 FR FR9312136A patent/FR2711140B1/fr not_active Expired - Fee Related
-
1994
- 1994-10-10 EP EP94402263A patent/EP0647629B1/fr not_active Expired - Lifetime
- 1994-10-10 DE DE69419377T patent/DE69419377D1/de not_active Expired - Lifetime
- 1994-10-10 AT AT94402263T patent/ATE181911T1/de not_active IP Right Cessation
- 1994-10-11 TW TW083109399A patent/TW300890B/zh active
- 1994-10-11 IL IL11123994A patent/IL111239A0/xx unknown
- 1994-10-11 NO NO943837A patent/NO304595B1/no unknown
- 1994-10-11 HU HU9402933A patent/HUT70048A/hu unknown
- 1994-10-11 FI FI944770A patent/FI944770L/fi unknown
- 1994-10-11 US US08/320,270 patent/US5502059A/en not_active Expired - Fee Related
- 1994-10-11 CA CA002117821A patent/CA2117821A1/en not_active Abandoned
- 1994-10-11 RU RU94036749A patent/RU2140912C1/ru active
- 1994-10-12 NZ NZ264661A patent/NZ264661A/en unknown
- 1994-10-12 AU AU75753/94A patent/AU685154B2/en not_active Ceased
- 1994-10-12 KR KR1019940026157A patent/KR950011413A/ko not_active Ceased
- 1994-10-12 CN CN94117090A patent/CN1108651A/zh active Pending
- 1994-10-12 JP JP6246609A patent/JPH07278114A/ja not_active Withdrawn
- 1994-10-12 ZA ZA947957A patent/ZA947957B/xx unknown
-
1995
- 1995-05-16 US US08/442,106 patent/US5523455A/en not_active Expired - Fee Related
- 1995-05-16 US US08/442,105 patent/US5585497A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0647629A1 (fr) | 1995-04-12 |
| ATE181911T1 (de) | 1999-07-15 |
| FI944770A7 (fi) | 1995-04-13 |
| ZA947957B (en) | 1995-05-22 |
| DE69419377D1 (de) | 1999-08-12 |
| NO943837L (no) | 1995-04-18 |
| FI944770L (fi) | 1995-04-13 |
| KR950011413A (ko) | 1995-05-15 |
| US5585497A (en) | 1996-12-17 |
| US5502059A (en) | 1996-03-26 |
| AU685154B2 (en) | 1998-01-15 |
| US5523455A (en) | 1996-06-04 |
| FR2711140A1 (fr) | 1995-04-21 |
| TW300890B (OSRAM) | 1997-03-21 |
| RU94036749A (ru) | 1996-10-10 |
| EP0647629B1 (fr) | 1999-07-07 |
| NO943837D0 (no) | 1994-10-11 |
| JPH07278114A (ja) | 1995-10-24 |
| FI944770A0 (fi) | 1994-10-11 |
| CA2117821A1 (en) | 1995-04-13 |
| NO304595B1 (no) | 1999-01-18 |
| HU9402933D0 (en) | 1995-01-30 |
| AU7575394A (en) | 1995-05-04 |
| CN1108651A (zh) | 1995-09-20 |
| FR2711140B1 (fr) | 1996-01-05 |
| RU2140912C1 (ru) | 1999-11-10 |
| HUT70048A (en) | 1995-09-28 |
| IL111239A0 (en) | 1994-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5502059A (en) | Substituted 1-naphthyl-3-pyrazolecarboxamides which are active on neurotensin, their preparation and pharmaceutical compositions containing them | |
| AU709119B2 (en) | Substituted 1-phenyl-3-pyrazolecarboxamides active on nurotensin receptors, their preparation and pharmaceutical compositions containing them | |
| EP0358398B1 (en) | Cycloalkyl-substituted glutaramide antihypertensive agents | |
| US7288562B2 (en) | Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists | |
| JP5291623B2 (ja) | 新規化合物 | |
| CZ117293A3 (en) | Novel pyrazole derivatives, process of their preparation and pharmaceutical preparations in which they are comprised | |
| JP2005504737A (ja) | Ｎ−（３−アミノ−２−ヒドロキシ−プロピル）置換アルキルアミド化合物 | |
| JP3020281B2 (ja) | 新規なトリアゾロプリン類、その調製方法及び医薬組成物としての使用 | |
| SU1581222A3 (ru) | Способ получени производных 4(3Н)-оксо-5,6,7,8-тетрагидропиридо(2,3- @ )пиримидина или их таутомерных форм | |
| AU705008B2 (en) | Naphthylhydrazine derivatives | |
| ES2207464T3 (es) | Procedimiento para preparar 8-ciclopentil-6-etil-3-(sustituido)-5,8-dihidro-4h-1,2,3a,7,8,pentaaza-as-indacenos y productos intermedios utiles en el mismo. | |
| JPH05508646A (ja) | 抗コレシストキニン活性を有するアスパラギン酸及びグルタミン酸誘導体 | |
| CN102558062B (zh) | 咪唑-氨基酸衍生物和相关化合物的合成方法 | |
| JPH09505304A (ja) | 非ペプチド性タキキニン受容体拮抗物質 |